bluebird bio
BLUE
#9803
Rank
NZ$84.24 M
Marketcap
NZ$8.60
Share price
0.00%
Change (1 day)
-75.19%
Change (1 year)

Market capitalization of bluebird bio (BLUE)

Last known market cap: NZ$84.24 Million

As of December 2025 bluebird bio has a market cap of NZ$84.24 Million. This makes bluebird bio the world's 9803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of bluebird bio from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$84.24 M-41.44%
2024NZ$0.14 B-65.8%
2023NZ$0.42 B-53.46%
2022NZ$0.90 B-11.87%
2021NZ$1.02 B-74.24%
2020NZ$3.98 B-44.83%
2019NZ$7.21 B-10.88%
2018NZ$8.09 B-34.22%
2017NZ$12.30 B270.37%
2016NZ$3.32 B-4.02%
2015NZ$3.46 B-8.56%
2014NZ$3.78 B519.4%
2013NZ$0.61 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
NZ$17.75 B 20,979.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.92 B 22,361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$209.27 B 248,312.96%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
NZ$0.28 B 242.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$431.15 B 511,686.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$17.53 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA